Zero Staff Time Cognitive Screening for Post-Acute Care
Key Facts
- GIA enables zero staff time cognitive screening in post-acute care settings.
- Screens for cognitive decline with 70.8% accuracy.
- GIA integrates with leading EHR systems such as PointClickCare and Epic.
- Screens take under 5 minutes, with results in 60 seconds.
- Screens for 46 conditions, including anxiety (77.5% accuracy) and depression (81.6% accuracy).
This article discusses how to screen post-acute care residents for cognitive decline without staff involvement. GIA, a Digital Human, offers zero staff time cognitive screening, enhancing resident care and addressing staffing challenges.
What Factors Contribute to Staffing Shortages in Post-Acute Care?
Post-acute care staffing shortages are caused by increasing patient demands and limited staff. This shortage impacts care quality, delaying cognitive screenings and leading to missed diagnoses. Traditional assessments require dedicated staff time, which increases burnout. GIA offers a method that minimizes staff involvement, allowing them to focus on core responsibilities while ensuring timely cognitive screenings for all residents.
How Does GIA™ Provide Zero Staff Time Cognitive Screening?
GIA provides zero staff time cognitive screening by independently conducting the entire screening process. GIA uses a Samsung Health Grade Galaxy device with Samsung Knox to engage residents in a natural, conversational assessment, evaluating their cognitive function through speech biomarkers. The entire interaction takes under 5 minutes, and results are available in just 60 seconds. GIA's screening for cognitive decline has 70.8% accuracy. GIA screens for 46 conditions (24 live, 22 coming soon), including depression (81.6% accuracy) and anxiety (77.5% accuracy), and speaks 92 languages. A clinician reviews and approves the results before they enter the clinical record. GIA screens, but does not diagnose.
The Operator's Guide to Multimodal Clinical AI
What administrators, DONs, and regional operators need to know before evaluating clinical AI platforms. Covers EHR integration, staffing impact, reimbursement codes, and deployment timelines.
How Does GIA™ Integrate with Existing EHR Systems?
GIA integrates with existing EHR systems by automatically documenting screening results directly into the resident's chart. GIA integrates with leading EHR platforms such as PointClickCare, Epic, Cerner, MatrixCare, and American HealthTech. GIA can administer Activities of Daily Living (ADLs) and Instrumental Activities of Daily Living (IADLs) assessments, with results written back to the EHR. This eliminates manual data entry and reduces errors.
Why is Addressing Undiagnosed Cognitive Impairment Important?
Addressing undiagnosed cognitive impairment is important because early detection allows for better care planning and resource allocation. Mild Cognitive Impairment (MCI) affects an estimated 12 million Americans, yet 92% are unaware of their condition. GIA helps identify at-risk individuals, enabling timely interventions and improved quality of life. GIA helps facilities adhere to CMS F-Tag 605.
How Does GIA™ Enhance Accuracy and Clinical Confidence?
GIA enhances accuracy and clinical confidence by providing objective data to support decision-making. GIA's screening for cognitive decline has 70.8% accuracy. GIA is 510(k) cleared and HIPAA compliant. The system uses over 2,500 speech biomarkers to analyze cognitive function. A clinician reviews and approves the results before they enter the clinical record. GIA augments clinical expertise.
Conclusion
Implementing zero staff time cognitive screening with GIA offers a method to the staffing challenges facing the industry while enhancing resident care. By automating the screening process and integrating easily with existing EHR systems, GIA frees up valuable staff time, reduces the risk of missed diagnoses, and improves overall efficiency. Request a demo today to explore the possibilities and see GIA in action.
Sources & References
- Centers for Medicare & Medicaid Services (CMS). Quality measures and star ratings. cms.gov
- Alzheimer’s Association. 2024 Alzheimer’s Disease Facts and Figures. alz.org/facts
- Scienza Health clinical validation: 12.3M longitudinal PAC/LTC patient records, 27B clinical events.
- U.S. Food & Drug Administration. 510(k) device clearance database. fda.gov
David Kaiser is the Founder and CEO of Scienza Health, where he leads the development of GIA®, a Digital Human® that screens for 46 cognitive and neurological conditions using 2,500+ speech biomarkers in under 5 minutes. The platform is 510(k) cleared, HIPAA compliant, and has been validated on 12.3M patient records and 27B clinical events.
Frequently Asked Questions
How does GIA™ ensure resident privacy and data security?
GIA™ ensures resident privacy and data security by being fully HIPAA compliant. GIA™ uses Samsung Health Grade Galaxy devices with Samsung Knox. All resident data is encrypted and protected in accordance with industry best practices.
What happens if GIA™ identifies a resident who may have cognitive decline?
GIA™ does not diagnose cognitive decline. If GIA™ identifies a resident who may be at risk, the results are flagged and communicated to the clinical staff. The clinician reviews the results and determines the next steps, which may include further evaluation or referral to a specialist.
How much does GIA™ cost?
The cost of GIA™ varies based on the facility's specific needs and size. Flexible pricing options are available. Contact us for a personalized quote.
The Clinical Signal
Hear the latest episode on clinical AI screening in post-acute care.